Combination of CA 19-9 with CEMIP showed markedly improved AUROC over that of CA 19-9 alone in the diagnosis of pancreatic cancer against normal individuals (AUROC, 0.89 vs. 0.85; P = 0.0119) (Fig. 2A). This evidence concerns the gene CEMIP and pancreatic neoplasm.